These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 9267827

  • 41. Immunophenotypic profile of biomarkers related to anti-apoptotic and neural development pathways in the Ewing's family of tumors (EFT) and their therapeutic implications.
    Navarro S, Giraudo P, Karseladze AI, Smirnov A, Petrovichev N, Savelov N, Alvarado-Cabrero I, Llombart-Bosch A.
    Anticancer Res; 2007; 27(4B):2457-63. PubMed ID: 17695539
    [Abstract] [Full Text] [Related]

  • 42. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B, Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [Abstract] [Full Text] [Related]

  • 43. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
    Fanburg-Smith JC, Miettinen M.
    Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
    [Abstract] [Full Text] [Related]

  • 44. Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.
    Rao UN, Hood BL, Jones-Laughner JM, Sun M, Conrads TP.
    Hum Pathol; 2013 May; 44(5):725-33. PubMed ID: 23063503
    [Abstract] [Full Text] [Related]

  • 45. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
    Vujanić GM, Kelsey A, Perlman EJ, Sandstedt B, Beckwith JB.
    Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
    [Abstract] [Full Text] [Related]

  • 46. Primary malignant giant cell tumor of bone: "dedifferentiated" giant cell tumor.
    Meis JM, Dorfman HD, Nathanson SD, Haggar AM, Wu KK.
    Mod Pathol; 1989 Sep; 2(5):541-6. PubMed ID: 2554283
    [Abstract] [Full Text] [Related]

  • 47. Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.
    Matsuura S, Ishii T, Endo M, Takahashi Y, Setsu N, Yamamoto H, Tamiya S, Iwamoto Y, Oda Y.
    Hum Pathol; 2013 Feb; 44(2):237-43. PubMed ID: 22944296
    [Abstract] [Full Text] [Related]

  • 48. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I, Birner P, Trieb K, Lang S, Chott A.
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [Abstract] [Full Text] [Related]

  • 49. [Association of nm23-H1 with orthopedic oncological conditions].
    Ha L, Guo W, Feng C, Li H.
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):477-9. PubMed ID: 11825445
    [Abstract] [Full Text] [Related]

  • 50. Prostaglandin levels of primary bone tumor tissues correlate with peritumoral edema demonstrated by magnetic resonance imaging.
    Yamamura S, Sato K, Sugiura H, Katagiri H, Ando Y, Fukatsu H, Iwata H.
    Cancer; 1997 Jan 15; 79(2):255-61. PubMed ID: 9010098
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma.
    Naka T, Boltze C, Samii A, Samii M, Herold C, Ostertag H, Iwamoto Y, Oda Y, Tsuneyoshi M, Kuester D, Roessner A.
    Histopathology; 2009 Apr 15; 54(5):607-13. PubMed ID: 19302530
    [Abstract] [Full Text] [Related]

  • 53. Malignant bone tumors.
    Weber K, Damron TA, Frassica FJ, Sim FH.
    Instr Course Lect; 2008 Apr 15; 57():673-88. PubMed ID: 18399615
    [Abstract] [Full Text] [Related]

  • 54. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.
    Tarkkanen M, Larramendy ML, Böhling T, Serra M, Hattinger CM, Kivioja A, Elomaa I, Picci P, Knuutila S.
    Eur J Cancer; 2006 May 15; 42(8):1172-80. PubMed ID: 16630715
    [Abstract] [Full Text] [Related]

  • 55. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X, Gao L, Zhe X.
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct 15; 26(5):270-2. PubMed ID: 10374333
    [Abstract] [Full Text] [Related]

  • 56. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, Thomas JR.
    Cancer; 1998 Feb 01; 82(3):474-83. PubMed ID: 9452264
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations.
    Roessner A, Mellin W, Hiddemann W, Voss B, Vollmer E, Grundmann E.
    Semin Diagn Pathol; 1984 Aug 01; 1(3):199-214. PubMed ID: 6600111
    [Abstract] [Full Text] [Related]

  • 59. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors.
    Toma CD, Svoboda M, Arrich F, Ekmekcioglu C, Assadian O, Thalhammer T.
    J Pineal Res; 2007 Sep 01; 43(2):206-13. PubMed ID: 17645699
    [Abstract] [Full Text] [Related]

  • 60. Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation.
    George E, Niehans GA, Swanson PE, Strickler JG, Singleton TP.
    Arch Pathol Lab Med; 1992 Oct 01; 116(10):1033-5. PubMed ID: 1358045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.